In May 2024, FDA finalized a rule regarding LDTs, which purported to amend the 21 CFR 809.3(a) definition of "in vitro diagnostic products" to specify that such definition "[includes] when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback